Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Adjuvant chemotherapy for malignant phyllodes tumor of the breast

Breadcrumb

  • Home
  • Adjuvant chemotherapy for malignant phyllodes tumor of the breast

Bruno Henrique Rala de Paula 1, 2, *, Renata de Souza Guerra 2, Carlos Augusto Moreira de Sousa 3 and Susanne Crocamo 3

1 Department of Oncology – University of Cambridge, Cambridge, United Kingdom.
2 University of Vassouras, Vassouras, Brazil.
3 Instituto Nacional de Cancer (INCA), Rio de Janeiro, Brazil
 
Review Article
World Journal of Advanced Research and Reviews, 2020, 05(03), 048-054
Article DOI: 10.30574/wjarr.2020.5.3.0052
DOI url: https://doi.org/10.30574/wjarr.2020.5.3.0052
 
Received on 25 February 2020; revised on 05 March 2020; accepted on 06 March 2020
 
Malignant phyllodes tumor of the breast (MPTB) is rare and usually presents as a large rapidly progressive mass which might metastasize distantly. The survival benefit of breast surgery is unquestionable; on the other hand, adjuvant radiotherapy and chemotherapy are controversial. In this study, chemotherapy endpoints are reviewed and underlying factors related to the outcomes are discussed. We performed a systematic review based on studies reporting disease-free survival (DFS) and/or overall survival (OS) rates with chemotherapy as variable in MPTB patients. The search generated 246 studies and 3 were included. They present together 199 patients, 77 (39%) with aggressive histology and 29 (15%) received chemotherapy. One study reported better DFS and OS outcomes in treatment group whilst two reported the opposite, but neither results were statistically significant. Unbalanced arms, small sample size, absence of prognostic factors stratification and inclusion of indolent subtypes are factors that might have contributed to these results. Therefore, the negative benefit of adjuvant chemotherapy in survival of MPTB is based on few studies with considerable limitations. High risk MPTB should be properly studied in randomized prospective trials, specially taking into account prognostic and predictive molecular markers of response.
 
Adjuvant chemotherapy; Breast cancer; Phyllodes
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2020-0052.pdf

Preview Article PDF

Bruno Henrique Rala de Paula, Renata de Souza Guerra, Carlos Augusto Moreira de Sousa and Susanne Crocamo. Adjuvant chemotherapy for malignant phyllodes tumor of the breast. World Journal of Advanced Research and Reviews, 2020, 5(3), 048-054. Article DOI: https://doi.org/10.30574/wjarr.2020.5.3.0052

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution